We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$2.92B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$217M |
| 2 |
Apple
AAPL
|
+$208M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Amazon
AMZN
|
+$136M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Gilead Sciences
GILD
|
+$107M |
| 3 |
PR
Permian Resources
PR
|
+$85.4M |
| 4 |
Reddit
RDDT
|
+$84.1M |
| 5 |
Keysight
KEYS
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 25.64% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 6.88% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
General Dynamics
GD
$104B
| $243K | ﹤0.01% |
+921
| New | +$265K |
|
902
Sprout Social
SPT
$519M
| $233K | ﹤0.01% |
+7,588
| New | +$228K |
|
|
MLNK
903
DELISTED
MeridianLink
MLNK
| $219K | ﹤0.01% |
+10,584
| New | +$233K |
|
904
nCino
NCNO
$2.11B
| $216K | ﹤0.01% |
+6,444
| New | +$240K |
|
|
TTAN
905
ServiceTitan Inc
TTAN
$8.25B
| $210K | ﹤0.01% |
+2,046
| New | +$214K |
|
906
News Corp Class B
NWS
$17.9B
| $205K | ﹤0.01% |
+6,724
| New | +$203K |
|
907
Caribou Biosciences
CRBU
$160M
| $194K | ﹤0.01% |
122,135
| – | – |
|
|
KLRS
908
Kalaris Therapeutics
KLRS
$99.7M
| $190K | ﹤0.01% |
+19,646
| New | +$297K |
|
909
CervoMed
CRVO
$26M
| $175K | ﹤0.01% |
+74,852
| New | +$728K |
|
910
Lexicon Pharmaceuticals
LXRX
$1.09B
| $169K | ﹤0.01% |
229,376
-982,548
| -81% | -$1.18M |
|
911
UiPath
PATH
$7.16B
| $169K | ﹤0.01% |
13,309
-6,185
| -32% | -$81.8K |
|
|
BASE
912
DELISTED
Couchbase
BASE
| $166K | ﹤0.01% |
10,623
-22,241
| -68% | -$380K |
|
913
Amplitude
AMPL
$1.33B
| $138K | ﹤0.01% |
13,078
-81,145
| -86% | -$812K |
|
|
OMGA
914
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $91.1K | ﹤0.01% |
+122,191
| New | +$122K |
|
915
Karyopharm Therapeutics
KPTI
$43.3M
| $90.7K | ﹤0.01% |
8,941
| – | – |
|
916
Tenaya Therapeutics
TNYA
$170M
| $27.6K | ﹤0.01% |
+19,294
| New | +$43.3K |
|
|
APLT
917
DELISTED
Applied Therapeutics
APLT
| $22.9K | ﹤0.01% |
+26,786
| New | +$168K |
|
918
Acadia Healthcare
ACHC
$3B
| – | – |
-748,313
| Closed | -$47.5M |
|
919
American Financial Group
AFG
$12.2B
| – | – |
-99,841
| Closed | -$13.4M |
|
920
C3.ai
AI
$1.54B
| – | – |
-22,506
| Closed | -$545K |
|
921
Aligos Therapeutics
ALGS
$29.3M
| – | – |
-91,971
| Closed | -$796K |
|
922
Alkami Technology
ALKT
$2.01B
| – | – |
-30,623
| Closed | -$966K |
|
923
American Homes 4 Rent
AMH
$12.4B
| – | – |
-415,814
| Closed | -$16M |
|
924
ANI Pharmaceuticals
ANIP
$1.82B
| – | – |
-156,488
| Closed | -$9.34M |
|
925
A.O. Smith
AOS
$8.59B
| – | – |
-104,240
| Closed | -$9.36M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.
- Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
- Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
- Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
- Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
- Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
- Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
- Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.